Autolus Therapeutics plc (FRA:6A3A)
Germany · Delayed Price · Currency is EUR 1.180
+0.050 (4.42%)
At close: Mar 27, 2026
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of €279.52 million as of March 27, 2026. Its market cap has decreased by -39.63% in one year.
Market Cap
279.52M
Enterprise Value
18.51M
Revenue
64.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.18
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from 833.42M to 279.52M, a decrease of -66.46%. That is a compound annual growth rate of -13.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 279.52M | -38.03% |
| Dec 31, 2025 | 451.08M | -25.33% |
| Dec 31, 2024 | 604.06M | -40.39% |
| Dec 29, 2023 | 1.01B | 229.38% |
| Dec 30, 2022 | 307.67M | -7.54% |
| Dec 31, 2021 | 332.77M | -12.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.41B |
| Darwin AG | 92.40M |
| 2invest AG | 62.87M |
| Biomark Diagnostics | 37.20M |
| co.don AG | 360.77K |
| bioXXmed AG | 323.52K |
| Paion AG | 231.13K |
| MagForce AG | 137.58K |